Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Wockhardt Limited, commonly referred to as Wockhardt, is a prominent pharmaceutical preparation manufacturer headquartered in India. Established in 1968, the company has grown to become a key player in the global healthcare industry, with significant operations across Asia, Europe, and North America. Specialising in the development and production of innovative medicines, biopharmaceuticals, and active pharmaceutical ingredients (APIs), Wockhardt is recognised for its commitment to quality and research-driven solutions.
The company’s core offerings include prescription medicines, vaccines, and sterile injectables, which are distinguished by their high standards and advanced manufacturing processes. Wockhardt’s notable achievements include a strong market position in both domestic and international markets, driven by a focus on healthcare innovation and regulatory compliance. As a leader in pharmaceutical preparation manufacturing, Wockhardt continues to contribute significantly to global health through its diverse portfolio and strategic growth initiatives.
+5 vs industry average
Wockhardt’s score of 47 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Wockhardt, a Pharmaceutical Preparation Manufacturing company headquartered in India, reported total emissions of approximately 70.4 million kg CO2e in 2026. This figure comprises about 10.4 million kg CO2e from Scope 1 emissions, approximately 49.6 million kg CO2e from Scope 2 emissions, and around 10.3 million kg CO2e from Scope 3 emissions.
In 2025, the company's total emissions were approximately 79.1 million kg CO2e, with Scope 1 emissions at about 8.7 million kg CO2e, Scope 2 at roughly 61.3 million kg CO2e, and Scope 3 at around 9.0 million kg CO2e. For 2024, Wockhardt's total emissions were approximately 66.2 million kg CO2e, consisting of about 10.1 million kg CO2e from Scope 1, approximately 55.8 million kg CO2e from Scope 2, and about 0.3 million kg CO2e from Scope 3.
Looking back, in 2023, the company reported Scope 1 emissions of approximately 19.2 million kg CO2e and Scope 2 emissions of around 112.7 million kg CO2e. In 2022, Scope 1 emissions were approximately 32.8 million kg CO2e, and Scope 2 emissions were about 143.9 million kg CO2e.
Wockhardt is committed to reducing its carbon footprint, aiming for a 50% decrease in absolute Scope 1 emissions by 2030, using 2021 as the baseline. Similarly, the company targets a 50% decrease in absolute Scope 2 emissions by 2030, also against a 2021 baseline.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more